title: Should patients be screened for hereditary cancer syndromes before starting anti-TNF-α therapy?
authors: K
authors: K
authors: Subramaniam
authors: K
authors: K
authors: Tucker
authors: P
authors: P
authors: Craft
authors: P
authors: P
authors: Pavli
mesh_terms: D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D009386:Neoplastic Syndromes, Hereditary / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control; D011379:Prognosis; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha